by Aiden Tuan | Feb 20, 2025 | ScienceWire
New member John Higgins in their most recent piece examines a novel technique by the Fred Hutch Cancer Center called targeted protein degradation that could be able to overcome the shortfalls of regular inhibitors. Usually cancer medicine works by inhibiting specific...
by Susan Keown | Jul 6, 2021 | ScienceWire
Diane Mapes (@double_whammied) writes for Fred Hutch News Service about the disparities in cancer prevention, care and research for Black Americans, and the efforts of teams in the Fred Hutch/University of Washington Cancer Consortium to reduce these inequalities....
by Chris Tachibana | Feb 2, 2020 | ScienceWire
Susan Keown takes us through the twists and turns of a clinical mystery—why a cancer that responded to T-cell immunotherapy became resistant. Susan (@sejkeown) won the 2019 Best of the Northwest Science Institutional Writing Award for her story, “Revealing a new way...
by Chris Tachibana | Nov 3, 2017 | ScienceWire
Rachel Tompa and the Fred Hutchinson Cancer Research Center scientists she works with answer the burning question of all Seattleites: What’s in all that Canadian Goose crap on our sidewalks? The answer is a previously unknown virus, @Rachel_Tompa explains. She...
by Chris Tachibana | Oct 1, 2017 | ScienceWire
“I’ll never complain I’m tired again,” tweeted Susan Keown, @sejkeown, after telling the story of Tiffany, a teacher, mother of three, master’s student, and patient with a rare cancer who spent a decade in treatment. Tiffany was also...
